Connect with us

Business

BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping.
Advertisement

Business

S&P 500 Snapshot: Rough Start But Solid Finish

Business

Get Ready for New Chip Shortages. Micron’s Success All but Guarantees It.

Business

Beyond The S&P 500: Why VEU Could Outperform Again In 2026

Business

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped.

Business

Politics And The Markets 12/21/25

Business

Celestica Enjoys 217% Boom Amid AI, Data Center Frenzy. Is More Growth Ahead?

Business

GRNJ: A Small- And Mid-Cap Growth ETF To Closely Watch In 2026 (NYSEARCA:GRNJ)

Business

S&P 500 Hovers Near Record With Wall Street Hoping for a Year-End Rally

Business

CWS: Quality, Concentration Do Not Translate Into Outperformance

Business

LRCX Stock Hits All-Time High On 2026 Prospects

Business

TLTW: Covered Call Treasury ETF, Double-Digit Distributions, Strong Momentum (BATS:TLTW)

Business

NMC to benefit from TriNetX’s database of over 318mn global patients

Business

Lamb Weston, Intuitive Machines, Nike, Oracle

Business

The 1-Minute Market Report, December 21, 2025 (NYSEARCA:SPY)

Business

AD Ports Group intends to acquire controlling stake in Egyptian company

Business

Payoneer Stock (PAYO): Improving Fundamentals Are Yet To Reflect On The Quant Metrics

Business

Oil Futures End Down Week on Up Note

Business

Cannabis REIT Innovative Industrial Is A Great Option For Investing In The Sector (IIPR)

Business

Kuwait to launch dedicated banking crimes prosecution office in 2026

Business

Alamo Group's Risks Remain Elevated

Business

UAE drivers to turn fuel spend into property stakes

Business

Mag 7 Stocks Keep Bouncing Back

Business

Nikken Sekkei to design 350m-tall Trump Tower Dubai for Dar Global

Business

Crescent Energy: Vital Energy Acquisition Closes

Business

DIFC Courts embrace blockchain tools for complex digital asset cases

Business

Wage Growth Is Slowing as the Labor Market Cools. What It Means for Job Mobility.

Business

Kraft Heinz Shares Could Rebound In 2026

Business

Major power outage hits San Francisco

Business

UAE wealth tops $1.15tn as financial assets, real estate and cross-border holdings surge: BCG

Business

Venezuelan government rejects seizure of new vessel transporting oil

Business

Abu Dhabi turns to AI to cut water waste on farms

Business

Week’s Best: Tech and International Stocks Will Still Shine in 2026

Business

US intelligence indicates Putin’s war aims in Ukraine are unchanged

Business

Sharjah Ruler issues decree establishing University of the Art Sharjah

Business

PCAOB to Cut Chair’s Pay by More Than Half Amid SEC Pressure

Business

Seven dead in fatal plane crash including former NASCAR driver Greg Biffle

Business

Agentic AI Market Set to Skyrocket and Hit $199 Billion by 2034

Business

Dubai Customs to make AI a central element in future decision-making

Business

Tax Breaks Are the Biggest Win for Marijuana Businesses as Restrictions Ease

Business

BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping.

Published

2 hours ago

on

BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping.

BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping.

Source link

Related Topics:
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2025 Wordupnews.com